Recent Progress On Pyrazole Scaffold-based Antimycobacterial Agents.
Rangappa S Keri, Karam Chand, Thippeswamy Ramakrishnappa, Bhari Mallanna Nagaraja
Published 2015 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
New and reemerging infectious diseases will continue to pose serious global health threats well into the 21st century and according to the World Health Organization report, these are still the leading cause of death among humans worldwide. Among infectious diseases, tuberculosis claims approximately 2 million deaths per year worldwide. Also, agents that reduce the duration and complexity of the current therapy would have a major impact on the overall cure rate. Due to the development of resistance to conventional antibiotics there is a need for new therapeutic strategies to combat Mycobacterium tuberculosis. Subsequently, there is an urgent need for the development of new drug candidates with newer targets and alternative mechanism of action. In this perspective, pyrazole, one of the most important classes of heterocycles, has been the topic of research for thousands of researchers all over the world because of its wide spectrum of biological activities. To pave the way for future research, there is a need to collect the latest information in this promising area. In the present review, we have collated published reports on the pyrazole core to provide an insight so that its full therapeutic potential can be utilized for the treatment of tuberculosis. In this article, the possible structure-activity relationship of pyrazole analogs for designing better antituberculosis (anti-TB) agents has been discussed and is also helpful for new thoughts in the quest for rational designs of more active and less toxic pyrazole-based anti-TB drugs.
This paper references
Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
Şeref Demirayak (2004)
A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation.
Pethaiah Gunasekaran (2011)
Rifampicin and treatment of cholestatic pruritus
Alan Frederick Hofmann (2002)
Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators.
Palwinder Singh (2006)
Tuberculosis -A comprehensive Clinical reference
H. Simon Schaaf (2009)
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
Shaun R. Stauffer (2000)
Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Ravindra B Pathak (2012)
The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamide.
Richard Storer (1999)
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
Daniele Castagnolo (2008)
Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
Gerald A. Wächter (1996)
Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity.
Alessandro Balbi (2011)
Treatment of tuberculosis: present status and future prospects.
Philip C Onyebujoh (2005)
Bactericidal Activity of Streptomycin and Isoniazid Against Tubercle Bacilli
B. Singh (1954)
Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.
Rupesh C. Khunt (2012)
4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships.
María Encarnación Camacho (2004)
Synthesis and antitubercular activity of novel pyrazole–quinazolinone hybrid analogs
Unnat Pandit (2012)
Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?
James S. Rothel (2005)
The role of pyrazinamide in tuberculosis chemotherapy.
Mark A. Steele (1988)
Coumarinyl pyrazole derivatives of INH: promising antimycobacterial agents
Prashant Aragade (2012)
Synthesis and antiviral activities of pyrazole derivatives containing an oxime moiety.
Guiping Ouyang (2008)
Medicinal and Pharmaceutical Chemistry. By Harkishan Singh and V. K. Kapoor. Vallabh Prakashan Publishers, Delhi. 1996. viii + 671 pp. 19 × 25 cm. ISBN 81-85731-00-4. $70 (Rs 560).
John L. Neumeyer (1997)
Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase.
Matthew J. Graneto (2007)
Nonreplicating persistence of mycobacterium tuberculosis.
Lawrence G. Wayne (2001)
Molecular Properties Prediction and Synthesis of Novel Pyrazoline Carboxamide Analogs as Antitubercular Agents
Mohamed Jawed Ahsan (2012)
Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
Adnan A Bekhit (2008)
Robert Koch A Life In Medicine And Bacteriology
Melanie Keller (2016)
Fipronil: A new soil and foliar broad spectrum insecticide
F. Colliot (1992)
Green approach towards synthesis of substituted pyrazole-1,4-dihydro,9-oxa,1,2,6,8-tetrazacyclopentano[b]naphthalene-5-one derivatives as antimycobacterial agents
Santosh S. Chobe (2013)
Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues.
Mohamed Jawed Ahsan (2011)
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Sharad C. Karad (2014)
Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis.
Ming-Jun Zhu (2001)
Synthesis and biological evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Paul Horrocks (2013)
Heterocyclic Chemistry, 4th edition, New Age
R. K. Bansal (2013)
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Daniele Castagnolo (2009)
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla (2013)
Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
Amit R. Trivedi (2011)
Synthesis and fungicidal activity against Rhizoctonia solani of 2-alkyl (Alkylthio)-5-pyrazolyl-1,3,4-oxadiazoles (Thiadiazoles).
Hao Chen (2000)
Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection.
Troels Lillebaek (2002)
Treatment of multidrug-resistant tuberculosis.
Michael D. Iseman (1993)
Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
Rama Krishna Yadlapalli (2012)
Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Mohamed Jawed Ahsan (2011)
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation.
Rebecca Deprez-Poulain (2011)
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
Wallace T. Ashton (1993)
Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
Amit R. Trivedi (2011)
Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.
Romano Silvestri (2008)
Extrapulmonary tuberculosis: an overview.
Marjorie P Golden (2005)
P. J. Castro (2011)
A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
Nesrin Gökhan-Kelekçi (2007)
Discovery of new antitubercular agents by combining pyrazoline and benzoxazole pharmacophores: design, synthesis and insights into the binding interactions
Dharmarajsinh N. Rana (2013)
Tuberculosis: a comprehensive clinical reference. Editors: Schaaf HS, Zumla A. 1014 pages, Elsevier, Inc.; 2009, ISBN 978-1-4160-3988-4.
Douglas Wilson (2010)
Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents
Vikramdeep Monga (2013)
Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens.
B E Fink (1999)
Robert Koch - A Life in Medicine and Bacteriology
Thomas D. Brock (1988)
Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents.
J Y Liu (2013)
Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Amit Trivedi (2008)
Pyrazoles as Potent Antimicrobial Agents, Lambert
A. Harish (2012)
3(2H)‐pyridazinones: Some recent aspects of synthetic and medicinal chemistry
Péater Máatyus (1998)
Medicinal and pharmaceutical chemistry
John Bedford Stenlake (1979)
Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Mohamed Jawed Ahsan (2011)
Synthetic pyrazole derivatives as growth inhibitors of some phytopathogenic fungi.
Chiara Beatrice Vicentini (2007)
Saskia Bonjour (1824)
Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities.
Mohamed Abdel-Aziz (2009)
The chemical approach to the control of tuberculosis.
H. Herbert. Fox (1952)
Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Maria Grazia Mamolo (2001)
Antinociceptive, anti-inflammatory and antipyretic effects of 1.5-diphenyl-1H-Pyrazole-3-carbohydrazide, a new heterocyclic pyrazole derivative.
David do Carmo Malvar (2014)
Pyrazole scaffold: a remarkable tool in the development of anticancer agents.
Harish Kumar (2013)
N'-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene] 2/4-substituted hydrazides: synthesis and anticonvulsant activity.
Darpan Kaushik (2010)
Pyrazole derivatives. 5. Synthesis and antineoplastic activity of 3-(2-chloroethyl)-3,4-dihydro-4-oxopyrazolo[5,1-d]-1,2,3, 5-tetrazine-8-carboxamide and related compounds.
C. C. Cheng (1986)
One-pot synthesis of pyrazoline derivatised carbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities.
Tasneem Taj (2011)
Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
Shaun R. Stauffer (2001)
Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
Rossella Fioravanti (2010)
From 2000 to mid-2010: a fruitful decade for the synthesis of pyrazoles.
Santos Fustero (2011)
Effect of Pyrazinamide and Probenecid on Peritoneal Urate Transport Kinetics during Continuous Ambulatory Peritoneal Dialysis
Sophia Spaia (2000)
The synthesis of l-α-amino-β-(pyrazolyl-N)-propionic acid in Citrullus vulgaris
Naoyoshi Sugimoto (1960)
Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Pedro Eduardo Almeida da Silva (2008)
Synthesis of isoniazid from 4-cyanopyridine
T. P. Sycheva (2004)
Chapter 6 – The genus Mycobacterium and the Mycobacterium tuberculosis complex
John M. Grange (2009)
Synthesis and selective antitubercular and antimicrobial inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole derivatives
Praful T. Chovatia (2006)
Design, synthesis, and evaluation of novel ethambutol analogues.
Raghunandan Yendapally (2008)
History of the development of rifampin.
Piero Sensi (1983)
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.
Véronique Dartois (2010)
Voltammetric assay of rifampicin and isoniazid drugs, separately and combined in bulk, pharmaceutical formulations and human serum at a carbon paste electrode
E. Hammam (2004)
Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
Ramaiyan Manikannan (2010)
Experimental Chemotherapy of Tuberculosis. II. The Synthesis of Pyrazinamides and Related Compounds1
S. S. Kushner (1952)
Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents.
Namrata Anand (2013)
This paper is referenced by
Pyrazole amino acids: hydrogen bonding directed conformations of 3-amino-1H-pyrazole-5-carboxylic acid residue.
Anna Kusakiewicz-Dawid (2017)
Solution NMR Studies of Mycobacterium tuberculosis Proteins for Antibiotic Target Discovery
Do-Hee Kim (2017)
Telescoped continuous flow generation of a library of highly substituted 3-thio-1,2,4-triazoles
Mariana Celestina Frojuello Costa Bernstorff Damião (2017)
New benzothiazole/benzoxazole-pyrazole hybrids with potential as COX inhibitors: design, synthesis and anticancer activity evaluation
Amany Belal (2017)
Synthesis and antimicrobial studies of azomethine and N-arylamine derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-methicillin-resistant Staphylococcus aureus agents
J. Brider (2016)
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma.
Fangmin Chen (2019)
Ultrasonic Cavitation Facilitates Rapid Synthesis of Trisubstituted Pyrazole Scaffolds through Michael Addition/Domino Cyclization
Damodharan Kannan (2019)
Synthesis of tetra-substituted 5-trifluoromethylpyrazoles via sequential halogenation/palladium-catalyzed C-C and C-N cross-coupling.
Carson W. Wiethan (2016)
Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents.
Devin Allison (2017)
The Literature of Heterocyclic Chemistry, Part XV, 2015
Leonid I. Belen’kii (2018)
Synthetic Utilization of α,β‐Chalcone Dibromide In Heterocyclic Chemistry and Stereoselective Debromination
Raj Kamal (2019)
Microwave assisted synthesis, computational study and biological evaluation of novel quinolin-2(1H)-one based pyrazoline hybrids
Shivarudrappa H. Pattanashetty (2018)
Synthesis of New Oxindoles and Determination of Their Antibacterial Properties
Pablo E. Romo (2020)
Synthesis of Dihydrooxepino[3,2-c]Pyrazoles via Claisen Rearrangement and Ring-Closing Metathesis from 4-Allyloxy-1H-pyrazoles
Yoshihide Usami (2018)
Microwave-Assisted Synthesis and Cytotoxicity Evaluation of Some Novel Pyrazole Containing Imidiazole, Pyrazole, Oxazole, Thiadiazole and Benzochromene derivatives
Hend N. Hafez (2017)
Mild and Regioselective Synthesis of 3‐CF3‐Pyrazoles by the AgOTf‐Catalysed Reaction of CF3‐Ynones with Hydrazines
Maxim A Topchiy (2018)
Molecular structure, spectroscopic and docking analysis of 1,3-diphenylpyrazole-4-propionic acid: A good prostaglandin reductase inhibitor
Thirumurugan Kavitha (2018)
DEVELOPMENT OF NEW PYRAZOLE HYBRIDS AS ANTITUBERCULAR AGENTS: SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDY
Sameer I. Shaikh (2017)
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery.
Elisa Azzali (2017)
Synthetic profiles to pyrazolylquinoxalines
Mohammed Baashen (2018)
Hydroxy- and alkoxymethylation of polyfluoroalkyl pyrazoles
А. Е. Ivanova (2018)
Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Palmi Modi (2019)
First synthesis and further derivatization of furo[3,2-c]pyrazol-6-ones
Clément Jacob (2019)
Regiocontrolled N-, O- and C-methylation of 1-phenyl-3-polyfluoroalkyl-1H-pyrazol-5-ols
Natalia A. Nemytova (2018)
ANTI-TUBERCULAR AND ANTIMICROBIAL ACTIVITIES OF NOVEL HETEROCYCLIC SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
Krishna Veni Chikkula (2018)
Correction: The first computational study for the oxidative aromatization of pyrazolines and 1,4-dihydropyridines using 1,2,4-triazolinediones: an anomeric-based oxidation
Mahya Kiafar (2016)
Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1,2,4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines.
Vinay Pogaku (2019)
Recent Progress on Pyrazole Scaffold-Based Antimycobacterial Agents
Rangappa S Keri (2015)
Novel and convenient one-pot strategy for regioselective synthesis of new 5-aryl-3-methyl-1-phenyl-1,2-dihydro-7aH-pyrazolo[3,4-c]pyridazin-7a-ol derivatives
Mehdi Rimaz (2017)
Theoretical and experimental investigation of the polyeletrophilic β-enamino diketone: straightforward and highly regioselective synthesis of 1,4,5-trisubstituted pyrazoles and pyrazolo[3,4-d]pyridazinones
Michael J. V. da Silva (2016)
Sodium ascorbate as an expedient catalyst for green synthesis of polysubstituted 5-aminopyrazole-4-carbonitriles and 6-amino-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles
Hamzeh Kiyani (2018)
2-Naphthol-pyrazole conjugates as substrates in the Mannich reaction
Gheorghe Roman (2018)See more